§ Mr. Caborn
asked the Secretary of State for Social Services what evidence is available to him about the risks to women of the injectable contraceptive Depo Provera.
§ Mr. Kenneth Clarke
Evidence on the possible adverse effects of Depo Provera was considered by a panel of persons appointed to hear an application by Upjohn Ltd. for a product licence to market Depo Provera as a long-term contraceptive. The panel's report was submitted to us in April this year and copies were placed in the Library.